Sarah James
Stock Analyst at Cantor Fitzgerald
(0.99)
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
CNC Centene | Maintains: Overweight | 90 65 | 33.31 | 95.14% | 13 | Jul 2, 2025 | |
HUM Humana | Reiterates: Neutral | 290 290 | 239.68 | 20.99% | 21 | May 1, 2025 | |
ELV Elevance Health | Reiterates: Overweight | 485 485 | 347.84 | 39.43% | 20 | Apr 23, 2025 | |
CI Cigna Group | Maintains: Overweight | 350 365 | 319.75 | 14.15% | 21 | Mar 20, 2025 | |
TBRG TruBridge | Maintains: Overweight | 20 29 | 22.85 | 26.91% | 6 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 15 15 | 12.5 | 20% | 11 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 177 177 | 171.5 | 3.21% | 20 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 405 405 | 376.58 | 7.55% | 19 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 700 700 | 308.55 | 126.87% | 17 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 52 52 | 23.36 | 122.6% | 13 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 30 17 | 21.46 | -20.78% | 14 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 219 219 | 184.53 | 18.68% | 24 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 406 406 | 239.58 | 69.46% | 11 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 43 43 | 22.15 | 94.13% | 12 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 15 15 | n/a | n/a | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 16 16 | 4.06 | 294.09% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 62 62 | 67.43 | -8.05% | 14 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 5 5 | 1.58 | 216.46% | 8 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 10 10 | 8.29 | 20.63% | 2 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 101 101 | 96.1 | 5.1% | 7 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Equal-Weight | 133 | 142.56 | -6.71% | 6 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 42 | 20.95 | 100.48% | 3 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 6 5 | 4.46 | 12.11% | 2 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 7 5 | 4.65 | 7.53% | 2 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 31 34 | 39 | -12.82% | 3 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 50 57 | 40.82 | 39.64% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 14 21 | 13.57 | 54.75% | 3 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 15 18 | 16.47 | 9.29% | 2 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 39 | 56.2 | -30.6% | 1 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 212 206 | n/a | n/a | 3 | Oct 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 151 0 | n/a | n/a | 2 | Jan 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 193 | 74.67 | 158.47% | 2 | Sep 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 2 | Mar 1, 2017 |